TNF and inflammatory response: Bronchial asthma, a chronic disease affecting 330 million people worldwide, is characterized by airway inflammation and hyperresponsiveness (1, 2), with asthma patients having abnormally elevated levels of multiple inflammatory factors such as interleukin-1 (IL-1), IL-6, IL-17, and tumor necrosis factor-α (TNF-α) (3).